This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Cramer's 'Mad Money' Recap: Enjoy the Bounce (Final)

Misunderstood by Market

In the "Executive Decision" segment, Cramer sat down with Bill Marth, North American President and CEO of Teva Pharmaceuticals (TEVA), a stock which Cramer owns for his charitable trust, Action Alerts PLUS , and one which he said is misunderstood by the markets.

Marth joked with Cramer that the stock market is indeed difficult to understand, which is why Teva sticks with pharmaceuticals. He said that Teva is a solid company with solid gross margins and $100 billion worth of innovator value. The company plans to launch 25 new drugs in 2011, which will add an additional $12 to $13 billion in innovator value.

Marth explained that Copaxone, one of the company's flagship drugs, is in the middle of a patent lawsuit, but even if the company loses that suit, Copaxone is a difficult product to replicate without a new set of clinical trials which would greatly delay the launch of any competing products. He said that many investors also think of Copaxone as a one product venture, but that's not the case.

Marth also discounted any impact of competing oral therapy drugs to Copaxone by saying that Teva is working on their own oral therapies which will be available shortly.

Cramer continued his support for Teva, saying that the company has a consistent record of delivering on its promises.

Sell Block

Cramer reminded viewers on the importance of following rules, including the need to sell stocks that receive takeover bids.

Cramer said that once a takeover is announced, the upside in a stock is capped and investors must sell. In the case of Airgas (ARG), Cramer made an exception on Feb. 5 and told investors to hold on for a higher bid. In this rare case, breaking the rules worked, and the stock of Airgas climbed an additional 13%. Cramer said it's now time to sell.

Breaking the rules doesn't always work however, as Cramer noted with Potash (POT), a stock he also advised holding onto after the company received a bid on Aug 17. In this case, the deal was blocked by the Canadian government, sending shares lower.

Cramer said discipline always trumps conviction when it comes to takeovers. He then recommended selling Art Technology (ARTG), a stock he recommended on Jan. 29 and CommScope (CTV), a stock he recommended on June 22. Both stocks have received takeover bids and are up handedly.

Cramer concluded by illustrating his point with Fortinet (FTNT), a stock that recently rallied 145% on the rumor of a takeover from IBM (IBM). When Fortinet denied the rumor, the stock plummeted. "Always sell on a takeover, even if it's a rumor," said Cramer.
2 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
WFT $10.89 0.00%
AKAM $57.68 0.00%
BBY $31.95 0.00%
HAL $39.31 0.00%
QTM $0.89 0.00%


Chart of I:DJI
DOW 17,813.39 +1.20 0.01%
S&P 500 2,088.87 -0.27 -0.01%
NASDAQ 5,116.1430 +13.3350 0.26%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs